Asarfi Hospital Management Discusses Growth, Expansion, and Main Board Migration
Asarfi Hospital Limited's management participated in an Analyst/Investor Webinar on July 24, 2026. They provided an overview of business operations, financial performance, and strategic initiatives. Key highlights included consistent year-on-year revenue and PAT growth, a reiterated revenue target of ₹400 crore by FY2028, and updates on the expansion of oncology and cardiology services. The company is bidding for a 100-seat Medical College under PPP, establishing nursing colleges, and planning a Bone Marrow Transplant facility. Preparations for migration to the Main Board are underway, and an acquisition of a 70-bed hospital is being evaluated. No Unpublished Price Sensitive Information was disclosed.
Key Highlights
- Reiterated revenue target of ₹400 crore by FY2028.
- Oncology, cardiology, and neurosurgery identified as key growth drivers.
- Bidding for a 100-seat Medical College under PPP model.
- Initiated activities for Main Board migration and evaluating hospital acquisition.
- Consistent financial performance with YoY revenue and PAT growth highlighted.
Price Impact
More from ASARFI